product summary
Loading...
company name :
MedChem Express LLC
product type :
protein
product name :
Noggin Protein, Human (HEK293, Fc)
catalog :
HY-P70542
quantity :
10 μg;50 μg
price :
145;400 USD
more info or order :
product information
Catalog Number :
HY-P70542
Product Name :
Noggin Protein, Human (HEK293, Fc)
Product Type :
proteins
Host Species :
HEK293
Size :
10 μg;50 μg
List Price :
145;400 USD
Product Description :
Noggin protein is an important BMP inhibitor that plays an indispensable role in the neural tube, somite growth, cartilage morphogenesis, and joint formation. Its homodimeric structure promotes significant interactions with GDF5 and possibly GDF6, inhibiting chondrocyte differentiation. Noggin Protein, Human (HEK293, Fc) is the recombinant human-derived Noggin protein, expressed by HEK293 , with C-hFc labeled tag.
SpeciesSummary :
Human
Background :
Noggin protein emerges as a crucial inhibitor in the intricate realm of bone morphogenetic proteins (BMP) signaling, playing indispensable roles in neural tube and somite growth, as well as contributing to the intricate processes of cartilage morphogenesis and joint formation. Operating through its homodimeric structure, Noggin establishes a significant interaction with GDF5, and likely GDF6, exerting its inhibitory influence on chondrocyte differentiation. This molecular interplay underscores Noggin's pivotal position in regulating key aspects of embryonic development, emphasizing its nuanced involvement in sculpting the intricate patterns and structures critical for proper growth and morphogenesis.
ALTnames :
Noggin; NOG
Purity :
Greater than 95% as determined by reducing SDS-PAGE.
Buffer :
Lyophilized from a 0.2 μm filtered solution of PBS, pH 7.4.
Storage :
Room temperature in continental US;may vary elsewhere.
more info or order :
company information

MedChem Express LLC
18 Wilkinson Way, Princeton, NJ 08540
sales@medchemexpress.com
http://www.medchemexpress.com609-228-6898
headquarters: USA
related products
browse more products
questions and comments